Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke
Steven
S
Department of Nephrology, Ghent University Hospital, Ghent, Belgium. steven.vanlaecke@ugent.be
Desideri
Federico
F
Geerts
Anja
A
Van Vlierberghe
Hans
H
Berrevoet
Frederik
F
Rogiers
Xavier
X
Troisi
Roberto
R
de Hemptinne
Bernard
B
Vanholder
Raymond
R
Colle
Isabelle
I
D000328:Adult; D015415:Biomarkers; D016022:Case-Control Studies; D003586:Cytomegalovirus Infections / Q000150:complications; D003920:Diabetes Mellitus / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006085:Graft Survival; D006801:Humans; D006943:Hyperglycemia / Q000097:blood; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008107:Liver Diseases / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects; D008274:Magnesium / Q000097:blood*; D008297:Male; D008659:Metabolic Diseases / Q000209:etiology; D008875:Middle Aged; D015999:Multivariate Analysis; D016016:Proportional Hazards Models; D012306:Risk; D012307:Risk Factors; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D055815:Young Adult
D015415:Biomarkers; D007166:Immunosuppressive Agents; D008274:Magnesium; D016559:Tacrolimus